6-[(4R,7S,8S)-16-[[(5S)-3,3-difluoro-1-azabicyclo[3.2.0]heptan-5-yl]methoxy]-4-ethyl-13-fluoro-8-methyl-9-oxa-2,5,11,15,17-pentazatetracyclo[8.7.1.02,7.014,18]octadeca-1(17),10,12,14(18),15-pentaen-12-yl]-4-methyl-5-(trifluoromethyl)pyridin-2-amine
C29H32F6N8O2 — CID 174177042
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[(4R,7S,8S)-16-[[(5S)-3,3-difluoro-1-azabicyclo[3.2.0]heptan-5-yl]methoxy]-4-ethyl-13-fluoro-8-methyl-9-oxa-2,5,11,15,17-pentazatetracyclo[8.7.1.02,7.014,18]octadeca-1(17),10,12,14(18),15-pentaen-12-yl]-4-methyl-5-(trifluoromethyl)pyridin-2-amine
6-[(4R,7S,8S)-16-[[(5S)-3,3-difluoro-1-azabicyclo[3.2.0]heptan-5-yl]methoxy]-4-ethyl-13-fluoro-8-methyl-9-oxa-2,5,11,15,17-pentazatetracyclo[8.7.1.02,7.014,18]octadeca-1(17),10,12,14(18),15-pentaen-12-yl]-4-methyl-5-(trifluoromethyl)pyridin-2-amine (PubChem CID 174177042) has the molecular formula C29H32F6N8O2 and a molecular weight of 638.62 g/mol. Its IUPAC name is 6-[(4R,7S,8S)-16-[[(5S)-3,3-difluoro-1-azabicyclo[3.2.0]heptan-5-yl]methoxy]-4-ethyl-13-fluoro-8-methyl-9-oxa-2,5,11,15,17-pentazatetracyclo[8.7.1.02,7.014,18]octadeca-1(17),10,12,14(18),15-pentaen-12-yl]-4-methyl-5-(trifluoromethyl)pyridin-2-amine.
Molecular Properties
| Compound Name | 6-[(4R,7S,8S)-16-[[(5S)-3,3-difluoro-1-azabicyclo[3.2.0]heptan-5-yl]methoxy]-4-ethyl-13-fluoro-8-methyl-9-oxa-2,5,11,15,17-pentazatetracyclo[8.7.1.02,7.014,18]octadeca-1(17),10,12,14(18),15-pentaen-12-yl]-4-methyl-5-(trifluoromethyl)pyridin-2-amine |
|---|---|
| PubChem CID | 174177042 |
| Molecular Formula | C29H32F6N8O2 |
| Molecular Weight | 638.62 g/mol |
| Exact Mass | 638.26 |
| IUPAC Name | 6-[(4R,7S,8S)-16-[[(5S)-3,3-difluoro-1-azabicyclo[3.2.0]heptan-5-yl]methoxy]-4-ethyl-13-fluoro-8-methyl-9-oxa-2,5,11,15,17-pentazatetracyclo[8.7.1.02,7.014,18]octadeca-1(17),10,12,14(18),15-pentaen-12-yl]-4-methyl-5-(trifluoromethyl)pyridin-2-amine |
| SMILES | CC[C@@H]1CN2c3nc(OC[C@@]45CCN4CC(F)(F)C5)nc4c(F)c(-c5nc(N)cc(C)c5C(F)(F)F)nc(c34)O[C@@H](C)[C@@H]2CN1 |
| InChI | InChI=1S/C29H32F6N8O2/c1-4-15-9-43-16(8-37-15)14(3)45-25-18-21(20(30)23(39-25)22-19(29(33,34)35)13(2)7-17(36)38-22)40-26(41-24(18)43)44-12-27-5-6-42(27)11-28(31,32)10-27/h7,14-16,37H,4-6,8-12H2,1-3H3,(H2,36,38)/t14-,15+,16-,27-/m0/s1 |
| InChIKey | WVQGSWFFZUWVQB-XGRFXKQCSA-N |
| XLogP | 4.34 |
| TPSA | 114.55 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 638.62 |
| LogP ≤ 5 | 4.34 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174177042 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.